I totally agree. I don't think anything but some announcements regarding money and making money are going to shift the SP. No one seems interested in clinical results except people that are not influencing the SP. It's definitely a long game this one.
Ann: Data Update on First-in-Human Study of DurAVR at NY Valves, page-4
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $342.3M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $46.99K | 2.617K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 116 | $17.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.00 | 83 | 2 |
View Market Depth
| Last trade - 14.26pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |